ESMO 2019: Modern chemotherapy drug better than second targeted hormone therapy against resistant prostate cancer 30 Sep 2019 A modern chemotherapy drug is more effective for men with advanced prostate cancer than a second targeted hormone therapy in patients who have stopped responding to treatment, a major clinical trial shows. Find out more Show/Hide
Cancer researchers, family and friends gather to celebrate award of Queen’s Regius Professorship to Professor Johann de Bono 20 Sep 2018 Colleagues from across cancer research, family and friends came together to celebrate and mark the achievements of the ICR's Professor Johann de Bono, as he delivered a celebratory lecture to mark his appointment as the ICR's first Regius Professor of Cancer Research. Find out more Show/Hide
Professor Johann de Bono given 2018 AACR award for outstanding achievement 17 Apr 2018 The ICR's Professor Johann de Bono has been chosen to receive the 2018 AACR–Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research. Find out more Show/Hide